1521 related articles for article (PubMed ID: 33661905)
1. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
Leong A; Cole JB; Brenner LN; Meigs JB; Florez JC; Mercader JM
PLoS Med; 2021 Mar; 18(3):e1003553. PubMed ID: 33661905
[TBL] [Abstract][Full Text] [Related]
2. Cardiometabolic Risk Factors for COVID-19 Susceptibility and Severity: A Mendelian Randomization Analysis.
Leong A; Cole J; Brenner LN; Meigs JB; Florez JC; Mercader JM
medRxiv; 2020 Sep; ():. PubMed ID: 32909013
[TBL] [Abstract][Full Text] [Related]
3. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.
Freuer D; Linseisen J; Meisinger C
Metabolism; 2021 May; 118():154732. PubMed ID: 33631142
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk: A 2-Sample Mendelian Randomization Study.
Sood T; Perrot N; Chong M; Mohammadi-Shemirani P; Mushtaha M; Leong D; Rangarajan S; Hess S; Yusuf S; Gerstein HC; Paré G; Pigeyre M
JAMA Netw Open; 2023 Jul; 6(7):e2325914. PubMed ID: 37498601
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
Butler-Laporte G; Nakanishi T; Mooser V; Morrison DR; Abdullah T; Adeleye O; Mamlouk N; Kimchi N; Afrasiabi Z; Rezk N; Giliberti A; Renieri A; Chen Y; Zhou S; Forgetta V; Richards JB
PLoS Med; 2021 Jun; 18(6):e1003605. PubMed ID: 34061844
[TBL] [Abstract][Full Text] [Related]
6. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
Yoshikawa M; Asaba K; Nakayama T
BMC Med Genomics; 2021 Nov; 14(1):269. PubMed ID: 34774031
[TBL] [Abstract][Full Text] [Related]
7. Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study.
Lyall DM; Celis-Morales C; Ward J; Iliodromiti S; Anderson JJ; Gill JMR; Smith DJ; Ntuk UE; Mackay DF; Holmes MV; Sattar N; Pell JP
JAMA Cardiol; 2017 Aug; 2(8):882-889. PubMed ID: 28678979
[TBL] [Abstract][Full Text] [Related]
8. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
[TBL] [Abstract][Full Text] [Related]
9. Estimating causal effects of genetically predicted type 2 diabetes on COVID-19 in the East Asian population.
Yoshikawa M; Asaba K; Nakayama T
Front Endocrinol (Lausanne); 2022; 13():1014882. PubMed ID: 36568068
[TBL] [Abstract][Full Text] [Related]
10. Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients.
Qu HQ; Qu J; Glessner J; Hakonarson H
Metabolism; 2022 Apr; 129():155156. PubMed ID: 35101533
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study.
Au Yeung SL; Zhao JV; Schooling CM
BMC Med; 2021 Mar; 19(1):72. PubMed ID: 33757497
[TBL] [Abstract][Full Text] [Related]
12. Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease.
Zheng J; Zhang Y; Rasheed H; Walker V; Sugawara Y; Li J; Leng Y; Elsworth B; Wootton RE; Fang S; Yang Q; Burgess S; Haycock PC; Borges MC; Cho Y; Carnegie R; Howell A; Robinson J; Thomas LF; Brumpton BM; Hveem K; Hallan S; Franceschini N; Morris AP; Köttgen A; Pattaro C; Wuttke M; Yamamoto M; Kashihara N; Akiyama M; Kanai M; Matsuda K; Kamatani Y; Okada Y; Walters R; Millwood IY; Chen Z; Davey Smith G; Barbour S; Yu C; Åsvold BO; Zhang H; Gaunt TR
Int J Epidemiol; 2022 Jan; 50(6):1995-2010. PubMed ID: 34999880
[TBL] [Abstract][Full Text] [Related]
13. The impact of age-specific childhood body-mass index on adult cardiometabolic traits: a Mendelian randomization study.
Yang J; Kuang Y; Yang X; Li C; Qi M; Fu P; Zeng X
Front Endocrinol (Lausanne); 2023; 14():1159547. PubMed ID: 38288476
[TBL] [Abstract][Full Text] [Related]
14. Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study.
Kjaergaard AD; Teumer A; Witte DR; Stanzick KJ; Winkler TW; Burgess S; Ellervik C
Clin Chem; 2022 Mar; 68(3):461-472. PubMed ID: 34922334
[TBL] [Abstract][Full Text] [Related]
15. Causal Inference for Genetic Obesity, Cardiometabolic Profile and COVID-19 Susceptibility: A Mendelian Randomization Study.
Aung N; Khanji MY; Munroe PB; Petersen SE
Front Genet; 2020; 11():586308. PubMed ID: 33262790
[TBL] [Abstract][Full Text] [Related]
16. Assessing the genetic relationship between gastro-esophageal reflux disease and risk of COVID-19 infection.
Ong JS; Gharahkhani P; Vaughan TL; Whiteman D; Kendall BJ; MacGregor S
Hum Mol Genet; 2022 Feb; 31(3):471-480. PubMed ID: 34553760
[TBL] [Abstract][Full Text] [Related]
17. Negative Effects of Age at Menarche on Risk of Cardiometabolic Diseases in Adulthood: A Mendelian Randomization Study.
Cao M; Cui B
J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31614369
[TBL] [Abstract][Full Text] [Related]
18. The role of mitochondrial DNA copy number in cardiometabolic disease: a bidirectional two-sample mendelian randomization study.
Qin P; Qin T; Liang L; Li X; Jiang B; Wang X; Ma J; Hu F; Zhang M; Hu D
Cardiovasc Diabetol; 2024 Jan; 23(1):45. PubMed ID: 38282013
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Thyroid Function: A Bi-Directional Two-Sample Mendelian Randomization Study.
Li GH; Tang CM; Cheung CL
Thyroid; 2022 Sep; 32(9):1037-1050. PubMed ID: 35734897
[No Abstract] [Full Text] [Related]
20. Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
Richardson TG; Sanderson E; Elsworth B; Tilling K; Davey Smith G
BMJ; 2020 May; 369():m1203. PubMed ID: 32376654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
